Stocktoria

Camp4 Therapeutics Corp CAMP

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2024-10-11

Camp4 Therapeutics Corp statistics & valuation

Market cap$218.1M
P / S62.3×
P / B4.6×
Net margin-2298.5%
Return on equity-168.5%
FCF margin-852.8%
Return on capital-51.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-14083.10% -7943.40% -2298.50% 202320242025
Gross margin (%)
202320242025
Operating margin (%)
-14822.60% -8142.30% -1502.40% 202320242025
Return on equity (%)
-82.00% -168.50% 202320242025
Shares outstanding
460704 20.1M 51.9M 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-89.70% -66.10% -68.20% 202320242025
Free cash flow margin (%)
-12809.40% -7055.70% -852.80% 202320242025
Debt / equity (×)
202320242025
EPS ($)
-$124.80 -$11.04 -$2.65 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Operating margin-1502.4%-8142.3%-14822.6%
Net margin-2298.5%-7943.4%-14083.1%
FCF margin-852.8%-7055.7%-12809.4%
Return on assets-68.2%-66.1%-89.7%
Return on equity-168.5%-82.0%39.8%
Current ratio7.356.925.13

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.